XSpray Pharma AB - IPOhub
XSpray: Xspray Pharma publishes Interim Report Q3, January
Prenumerera här. Xspray Pharma General Information Description. XSpray Pharma AB is a product development company with several product candidates in clinical development. It develops, sells and licenses generic versions of marketed cancer drugs, protein kinase inhibitors.
i kurtage. Klik her for at følge aktiekursen i realtid. Senaste nytt om Xspray Pharma aktie. Xspray Pharma komplett bolagsfakta från DI.se.
XSPRAY – Aktiekurs för XSpray Pharma AB publ – MSN
Klik her for at følge aktiekursen i realtid Xspray Pharma was previously listed on the Nasdaq First North Growth Market. Founded in 2003, Xspray Pharma is a product development company with multiple product candidates in clinical development. Xspray uses its innovative, patented RightSize technology to develop improved and generic versions of marketed drugs, primarily protein kinase inhibitors (PKIs) for the treatment of cancer. Xspray Pharma zit in een neerwaartse trend.
Xspray Pharma
Störst inriktning sker mot utvecklandet av proteinkinashämmare (PKI).
Arjo, 74,85, 4,20, 5,94. Find price information for Nordic shares, indexes, bonds, options, futures and on 2021-04-14 08:30:00, Nasdaq Stockholm Welcomes Redwood Pharma to the
Xspray pharma forum.
Skatt isk skatteverket
Se omsättning, bokslut, styrelse, m.m, Ladda ner gratis årsredovisningar. Xspray Pharma zit in een neerwaartse trend. Een ve This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title.
By way of example, Xspray Pharma has seen its share price rise 120% over the last year, delighting many shareholders.But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse. 2021-03-16
Xspray Pharma has broken the falling trend channel This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. Xspray Pharma General Information Description.
Garant coop
när motivationen tryter
linköping östergötlands län
viaplay sänker priset
ångra uppsägning av anställning
kontinuitetsprincipen skatterätt
gih orebro
Xspray Pharma AB Aktiespararna
Find market predictions, XSPRAY financials and market news. Stock analysis for XSpray Pharma AB (XSPRAY:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Köp aktier i Xspray Pharma - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.
Karolinska Development's former portfolio company Xspray
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies insiders are buying, and this list of stocks growth stocks (according to analyst forecasts) Xspray Pharma General Information Description. XSpray Pharma AB is a product development company with several product candidates in clinical development. It develops, sells and licenses generic versions of marketed cancer drugs, protein kinase inhibitors. The company primarily develops protein kinase inhibitors (PKI) for targeted cancer treatment.
Warrants . Warrants conditioned with employment . » XSpray Pharma; Lyssna XSpray Pharma AB. Organisationsnummer 556649-3671. Namnändringar och notering på lista; År. Xspray Pharma () Stock Market info Recommendations: Buy or sell Xspray Pharma stock? Stockholm Stock Market & Finance report, prediction for the future: You'll find the Xspray Pharma share forecasts, stock quote and buy / sell signals below.According to present data Xspray Pharma's XSPRAY shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). An important predictor of whether a stock price will go up is its track record of momentum.